Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Edwards Lifesciences
MedTech
JenaValve secures FDA's 1st approval in aortic regurgitation
JenaValve has secured the FDA’s approval for its heart implant, making it the first in the U.S. to treat severe backflow through the aortic valve.
Conor Hale
Mar 18, 2026 10:05am
FTC wins case blocking Edwards' $945M JenaValve takeover
Jan 12, 2026 8:15am
Edwards nets FDA approval for Sapien M3 mitral valve replacement
Dec 23, 2025 11:00am
FTC outlines antitrust case against Edwards' JenaValve deal
Nov 25, 2025 3:10pm
Philips, Edwards roll out AI tech for heart implant procedures
Nov 17, 2025 2:18pm
At ESC 2025, researchers call for earlier, simpler TAVR
Aug 29, 2025 1:00pm
